Hi All,
As nothing further resulted from the Quarterly Report, for those interested, I'm posting a summary of my review of the Musuma Prospect based on the data that has been released so far.
I agree with IVZ's comments that it is a compelling prospect. What interests me most is the correlation, albeit just on the one line presented - CB23-15, between amplitude anomalies, flat-spots, the seismic interval velocity low and the structure's mapped extent on the line - with caveats as noted. We need to see these in map form to confirm this correlation.
IVZ make the comment that the strong Direct Hydrocarbon Indicators are very compelling. I would agree with this, but being amplitude based the percentage of gas fill causing the amplitude anomaly can result from very low amounts of gas charge, "fizzy" water, i.e. <10% gas charge - sub economic. This is why the correlation with other information is very important. They imply in the release that they have other lines of evidence that is compelling as well - would be nice for these to be released!!
As for Mukuyu, I was expecting, as no doubt were many others, that the PPSA & funding would have gone through in late 2023 & early 2024 to allow Mukuyu-2 deepening & testing to go ahead in early 2024. IMO, from the spectrum of information released I haven't changed my view on the accumulations massive potential, and considering Zimbabwe's energy crisis I'm astounded that further work has moved so slowly!!
GLTAH
Cheers
VOGC
- Forums
- ASX - By Stock
- IVZ
- Ann: Musuma-1 selected as high-impact exploration well
IVZ
invictus energy ltd
Add to My Watchlist
2.04%
!
5.0¢

Ann: Musuma-1 selected as high-impact exploration well, page-474
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
5.0¢ |
Change
0.001(2.04%) |
Mkt cap ! $80.17M |
Open | High | Low | Value | Volume |
5.0¢ | 5.2¢ | 4.8¢ | $228.7K | 4.596M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 290000 | 4.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.0¢ | 119195 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 290000 | 0.049 |
4 | 686333 | 0.047 |
7 | 865281 | 0.046 |
5 | 573334 | 0.045 |
1 | 222222 | 0.043 |
Price($) | Vol. | No. |
---|---|---|
0.050 | 119195 | 3 |
0.051 | 560000 | 3 |
0.052 | 338003 | 2 |
0.053 | 544105 | 3 |
0.054 | 529496 | 5 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
IVZ (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online